CPSE:DEMANTMedical Equipment
Assessing Demant (CPSE:DEMANT) Valuation After Job Cuts And Cautious 2026 Outlook
Demant (CPSE:DEMANT) has drawn fresh attention after its 2025 results combined softer net income with a cautious 2026 outlook and a plan to cut 700 jobs, prompting a sharp share price reaction.
See our latest analysis for Demant.
The latest earnings announcement, cautious 2026 guidance and cost saving plan have come on top of a weak run for the shares, with a 7 day share price return of 14.61% decline and a 1 year total shareholder return of 28.98% decline pointing to fading momentum.
If...